Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Bringing Back Innovation: FDA Science Board Discusses Biomaterials Access

This article was originally published in The Gray Sheet

Executive Summary

Further research into biomaterials, including the development of testing methodologies, would aid device development, participants suggested at an April 9 FDA Science Board meeting held in Rockville, Maryland
Advertisement

Related Content

Material Update: Study Proposed To Review Biomaterials Access Situation
Material Update: Study Proposed To Review Biomaterials Access Situation
Biomaterials Liability Bill Cleared For President's Signature
Biomaterials Liability Bill Cleared For President's Signature
Advertisement
UsernamePublicRestriction

Register

MT016401

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel